News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...


Recent Postings


Archive


Tags

Agenus (AGEN Sequenom (SQNM) Genentech Pluristem (PSTI) Velcade (bortezomib) Intrexon (XON) Dendreon (DNDN) Biocryst (BCRX) Ariad (ARIA) Advaxis (ADXS) C4 Therapeutics Bristol-Myers Squibb (BMY) AstraZeneca (AZN) Sanofi (SNA) Herceptin Aimmune Therapeutics (AIMT) Bellicum (BLCM) Sarepta (SRPT) Telaprevir SERES THERAPEUTICS (MCRB) Gilead (GILD) Spike Therapeutics (ONCE) Auspex (ASPX) Sanofi (SNY) Theravance Bio Pharma (TBPH) ARCA (ABIO) GlaxoSmithKline (GSK) Inovio (INO) Sanofi-Aventis (SAN) NEKTAR (NKTR)) Zerenex Benlysta (belimumab) Alder Biopharmaceuticals (ALDR) ACADIA (ACAD) Regeneron (REGN) Jazz Pharmaceuticals (JAZZ) Trastuzumab-DM1 Human Genome Sciences (HGSI) Merck (MRK) Sangamo (SGMO) Mirati Therapeutics (MRTX) Ridaforolimus Prosensa (RNA) KITE (KITE) Human Longevity (HLI) PTC Therapeutics (PTCT) ABBVIE (ABBV) Anadys (ANDS) Biogen Idec (BIIB) Array Pharmaceuticals (ARRY) Abbott Laboratories (ABT) Ocular Therapeutix (OCUL) RenenxBio (RGNX) AERIE PHARMACEUTICALS Adaptimmune (ADAP) OSI (OSIP) Endometrial Cancer VANDA (VNDA) Tysabri HALOZYME (HALO) Revlimid (lenolidamide) Incyte (INCY) ZALTRAP™ SUNESIS PHARMACEUTICALS (SNSS) ISIS (ISIS) Onyx (ONXX) Ziofpharm (ZIOP) IDERA (IDRA) Vertex (VRTX) galapagos (GLPG) CRISPR Therapeutics (CRSP) Illumina (ILMN) Exelixis (EXEL) Multiple Myeloma TOKAI (TKAOI) Vitae Pharmaceuticals (VTAE) GUARDIAN HEALTH Global Cell Therapeutics (GBT) KERYX (KERX) ARGOS (ARGS) Seattle Genetics (SGEN) Intercept (ICPT) Roche (RHHBY) Roche (ROCHE) CEMPRA (CEMP) NANTKWEST (NK) ADVENTRIX (ANX) Rapamune Ionis (IONS) Cytokinetics (CYTK) Alnylam (ALNY) Editas (EDIT) Xoma (XOMA) AGOS (ARGS) Amgen (AMGN) Theravance (THRX) ImmunoGen (IMGN) NOVOCURE (NVCR) Intermune (ITMN) Anacor (ANAC) MODERNA Micromet (MITI) CompuGen (CGEN) INNOVIVA (INVA) SYNTA (SNTA) Dynavax (DVAX) JUNO (JUNO) Agenus (AGEN) Prolor Biotech (PBTH) BIOMARIN (BMRN) REGULUS (RGLS) Valeant Pharmaceuticals International (VRX) Idenix (IDIX) Galena (GALE) Elan (ELN)